The NSW Government has committed over $9 million towards clinical trials to evaluate the safety and effectiveness of cannabis medicine in providing relief from the symptoms of serious conditions.
Children with severe, treatment-resistant epilepsy, through a partnership with the Sydney Children’s Hospitals Network.
Adults with chemotherapy-induced nausea and vomiting, where standard treatment is ineffective.
Adult palliative care patients, focusing on quality of life, particularly appetite and appetite-related symptoms
Adults with advanced cancer, focusing on the control of symptoms including pain, nausea and lack of appetite where standard treatments have proven ineffective.